WAVE Life Sciences Ltd Stock
WAVE Life Sciences Ltd Stock
A loss of -1.920% shows a downward development for WAVE Life Sciences Ltd.
The stock is an absolute favorite of our community with 28 Buy predictions and no Sell predictions.
Based on the current price of 5.1 € the target price of 19 € shows a potential of 272.55% for WAVE Life Sciences Ltd which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for WAVE Life Sciences Ltd stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of WAVE Life Sciences Ltd in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of WAVE Life Sciences Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| WAVE Life Sciences Ltd | -1.920% | 0.000% | -3.774% | -25.547% | -65.772% | 18.605% | 9.560% |
| Intellia Therapeutics Inc | -0.390% | 4.918% | -10.490% | 8.867% | 31.181% | -71.642% | -92.231% |
| Chromadex Corp | -0.760% | 3.175% | -14.474% | -69.767% | -52.727% | 80.556% | -63.380% |
| Cardio3 Biosciences S.A. | -0.430% | 9.524% | 26.374% | -32.945% | 70.370% | -56.439% | -93.343% |
Comments
WAVE Life Sciences (WVE) had its price target lowered by Mizuho from $27.00 to $23.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (WVE) had its "buy" rating reaffirmed by HC Wainwright.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (WVE) had its price target lowered by Citigroup Inc. from $24.00 to $19.00. They now have a "buy" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat